Share and Follow
In a significant move aimed at making weight-loss medications more affordable, President Donald Trump is set to unveil an agreement that could see the price of certain obesity drugs reduced to $149 per month in specific scenarios, according to recent reports.
WASHINGTON — On Thursday, President Trump is anticipated to announce a landmark deal that will slash prices on several widely-used weight-loss medications. The announcement is expected to take place at 11 a.m. ET.
Sources within the discussions have informed The Wall Street Journal that the agreement will focus on reducing costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. These GLP-1 medications currently carry a hefty price tag of over $1,000 per month when not covered by insurance. Additionally, the deal may include potential coverage options for Novo Nordisk’s diabetes drug, Ozempic.
According to insiders, this deal would enable the lowest dosages of these medications to be offered through the Trump administration’s TrumpRx initiative for as little as $149 a month in select cases. Moreover, the agreement could pave the way for Medicare and Medicaid to cover these drugs for certain patients, particularly those who are obese or face other serious health risks.
The reported deal would make the lowest doses of the drugs available through the administration’s TrumpRx initiative for as little as $149 a month in some cases. The sources also told the outlet that the deal could also allow Medicare and Medicaid to begin covering the drugs for some patients, including those who are obese or suffering from other high-risk health conditions.
It’s currently unclear how broadly the lower price would apply or which patients would qualify.
Weight-loss medications like Ozempic and Wegovy are already being offered to non-insured customers at several stores, including Costco, Sam’s Club and Hy-Vee.
Costco, Sam’s Club and Hy-Vee will all offer the medications at a fraction of the cost, selling for $499 a month. Customers do not need insurance to buy the drugs, though they still need a valid prescription.
A month’s supply of Wegovy can cost up to $1,350 without insurance or discounts, according to GoodRx.
Both drugs have the same main ingredient, Semaglutide, but differ in dosage. Wegovy is designed for chronic weight management, while Ozempic is meant to treat Type 2 diabetes.
